Skip to main content
NewslettersWatchlist

Organigram Holdings Inc(OGI-T)
TSX

Today's Change
Real-Time Last Update
Day Low2.56
Day High2.69
Open:2.64
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
the globe and mail
the globe and mail

Where’s the help for the cannabis industry in the 2024 budget?

Many had hoped that in the budget the federal government would announce its intention to initiate a review of the cannabis excise framework
Beena Goldenberg
Automated Summaries - The Globe and Mail
Closing Bell: Organigram Holdings Inc up on Friday (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (OGI)
The Globe and Mail
The Largest Companies in Atlantic Canada
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (OGI)
The Globe and Mail
Tuesday’s analyst upgrades and downgrades
The Globe and Mail
Wednesday’s analyst upgrades and downgrades
Baystreet
Stocks in play: Organigram Holdings Inc.
The Globe and Mail
Market movers: Stocks seeing action on Tuesday - and why
Baystreet
Stocks in play: Organigram Holdings Inc.
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Healthcare Sector Stocks on TSX (OGI)
Baystreet
Stocks in play: Organigram Holdings Inc.
Baystreet
Stocks in play: Organigram Holdings Inc.
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI)
Baystreet
Stocks in play: Organigram Holdings Inc.
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Growth Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Healthcare Sector Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 25 Undervalued Toronto Stock Exchange Stocks (OGI)
The Globe and Mail
Wednesday’s analyst upgrades and downgrades
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Healthcare Sector Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Small Cap Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI)
The Globe and Mail
‘Net-net’ stocks soared in 2023. What is on the list for 2024?
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Healthcare Sector Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 25 Undervalued Toronto Stock Exchange Stocks (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Small Cap Stocks on TSX (OGI)
The Globe and Mail
Organigram stock jumps on $124-million investment from tobacco giant BAT
SYNDTGAM
BAT increasing its stake in Organigram with $124.6-million investment
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Drug Manufacturers Industry Stocks (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Small Cap Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Growth Stocks on TSX (OGI)
AI-generated - The Globe and Mail
OrganiGram Holdings: Top 10 Undervalued Healthcare Sector Stocks on TSX (OGI)

Profile

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.